Forest Hills Lab is filing an IND to initiate a clinical phase 2 study on Parkinson’s disease with the US FDA
HONG KONG, March 23, 2021 /PRNewswire/ — Forest Hills Partners Hong Kong Limited (also known as Forest Hills Lab) is ready to file an Investigative New Drug (IND) application with the US FDA in April …
Discussion disabled.
Category: Dementia